Blog

28 May 2026

The 60-Second Consult: A Linear Eruption That Followed the Vaccination Site — for 2 Years

A 15-year-old male presented with a 2-year history of pruritic, erythematous, and scaly plaques confined to the right upper extremity....
Read more
The 60-Second Consult: A Linear Eruption That Followed the Vaccination Site — for 2 Years
Global Experts Unveil New Guidelines for Integrated Skin Care Success

Global Experts Unveil New Guidelines for Integrated Skin Care Success

Global experts reveal new guidelines on integrated skin care to boost healing, reduce irritation, and enhance results before and after...
27 05 2026
Read more
Financial Strain Worsens Quality of Life for Hidradenitis Suppurativa Patients

Financial Strain Worsens Quality of Life for Hidradenitis Suppurativa Patients

Financial strain worsens quality of life for hidradenitis suppurativa patients, highlighting the need to address financial toxicity in HS care.
26 05 2026
Read more
Upadacitinib Shows Stable Lab Safety in Atopic Dermatitis After 3 Years

Upadacitinib Shows Stable Lab Safety in Atopic Dermatitis After 3 Years

Upadacitinib shows stable lab safety over 3 years in moderate to severe atopic dermatitis, offering important insights for long-term treatment...
25 05 2026
Read more
How Dermatologists Tailor Sun Protection Advice for Every Skin Concern

How Dermatologists Tailor Sun Protection Advice for Every Skin Concern

Discover how dermatologists customize sun protection tips for different skin concerns, including mineral vs. chemical sunscreens and sensitive skin needs.
22 05 2026
Read more
Extended-Release Oral Minoxidil Shows Promise for Treating Hair Loss

Extended-Release Oral Minoxidil Shows Promise for Treating Hair Loss

Extended-release oral minoxidil shows promising results in treating androgenetic alopecia, offering a potential new FDA-approved option for hair loss.
23 05 2026
Read more
Bimekizumab Shows Superior Results Over Risankizumab in Psoriatic Arthritis Trial

Bimekizumab Shows Superior Results Over Risankizumab in Psoriatic Arthritis Trial

Bimekizumab outperforms risankizumab in a phase 3 trial for psoriatic arthritis, showing superior joint improvement at 16 weeks. Learn more...
24 05 2026
Read more
How Phages Could Transform Acne and Body Odor Treatments Naturally

How Phages Could Transform Acne and Body Odor Treatments Naturally

Discover how phages, natural bacteria-fighting viruses, could revolutionize acne and body odor treatments without antibiotics or harming your skin’s microbiome.
21 05 2026
Read more
Higher Starting Dose in Excimer Laser Speeds Vitiligo Repigmentation

Higher Starting Dose in Excimer Laser Speeds Vitiligo Repigmentation

Discover how a higher starting dose in excimer laser therapy speeds vitiligo repigmentation, offering faster, effective results without increased side...
20 05 2026
Read more